Search alternatives:
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
i point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
-
41
-
42
-
43
-
44
-
45
Mice carrying 100P mutations show layer-specific decreases in proportions of PV+ cells.
Published 2016“…<p>(<b>A-D</b>) Decreases occurred in layer IV in fSSp, SSp, vAud and Vis, in layer V in SSp, vAud and Vis and in layer II/III in SSp. …”
-
46
-
47
-
48
-
49
-
50
FUD transiently decreased IOP in mice injected with Ad5-TGFβ2 viral vector.
Published 2020“…(B) IOPs were monitored for 5 more days (until Day 22) in a subset of mice from A. …”
-
51
-
52
-
53
-
54
Drugs which cluster on the 'anxiolytic' group decrease 5-HT turnover in the brain.
Published 2014“…Bars represent mean (B) Correlation between turnover rates (<i>Y</i>-axis) and time spent in the white compartment (<i>X</i>-axis) for vehicle- and drug-treated animals (<i>n</i> = 4 for each point). …”
-
55
-
56
Eltrombopag markedly decreases levels of ROS in MOLM14 cells.
Published 2015“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”
-
57
Mice carrying 100P mutations show region-specific decreases in proportions of PV-expressing cells.
Published 2016“…<p>(<b>A</b>) Significant decreases in the proportions of PV+ cells were observed in fSSp, SSp, vAud and in Vis, but not MPFC. …”
-
58
-
59
-
60